Varian takes radiotherapy tech to Indonesia
This article was originally published in Clinica
Varian Medical Systems is set to make its radiotherapy technology available in Indonesia through the Siloam Hospitals group. For an undisclosed fee, the two parties have combined under a collaborative partnership to explore the opportunities for delivering cancer treatment in the country. According to Palo Alto, California-based Varian, there are almost 800,000 people in Indonesia who are afflicted with cancer each year, thus highlighting the need for advanced cancer treatment equipment in the region. Siloam currently owns four hospitals and one clinic in Jakarta and Surabaya, and is investing US$500m over the next five to ten years to build ten extra hospitals throughout the country.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals